As supply shortages during COVID-19 remain a challenge, GHX is expanding the “Critical Supplies” list to include therapeutics at-risk of supply shortage, using our Lumere Pharmacy Solution.
If you have a current Lumere login, you can access the research here. If you are not a current Lumere customer, please contact us to learn more about accessing our COVID-specific shortage research.
Please be aware that products considered for inclusion on this list are either recommended for use in certain patients hospitalized with COVID-19, highly suspected to be used in these patients, or being evaluated in a substantial number of COVID-19 clinical trials. Inclusion of an agent on this list should not be construed as support for its use in patients with COVID-19, particularly for agents used off-label. Consult expert guidelines for appropriate COVID-19 patient care.